Around 40% of adults worldwide are affected by osteopenia: a loss of bone mineral density. This condition is extremely common ...
Osteoporosis — a significant drop in bone density — can lead to fractures and disability if left untreated. Here are ways to prevent and treat the condition.
Everyday Health on MSN
Osteoporosis drugs that build and restore bone: Are these right for you?
Anabolic agents work differently from other osteoporosis medications in that they don't just slow down bone loss — they can trigger the growth of new bone.
Shockingly, according to a large-scale study, 50% of Indian adults show early signs of bone loss, with one in five people may ...
How can you keep your bones strong after 50? Discover five lifestyle changes that help protect bone health and prevent ...
Cracked teeth are the second most common dental problem at the National Dental Centre Singapore. Read more at ...
Bosaya(TM) and Aukelso(TM) (both denosumab-kyqq products) now available in the United States, following U.S. FDA approval in September 2025 with an interchangeable designation -- Potential benefit to ...
BENGALURU, India & BRIDGEWATER, N.J.-- (BUSINESS WIRE)--Apr 7, 2026-- ...
Alongside the approval of Ponlimsi, the FDA is reviewing a BLA for TEV-45779, a biosimilar candidate for Xolair, covering all currently approved indications.
Biocon makes US commercial launch of Bosaya and Aukelso, denosumab biosimilars: Our Bureau, Bengaluru Wednesday, April 8, 2026, 16:10 Hrs [IST] Biocon has made a commercial launch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results